The P110 subunit of PI3-K is a therapeutic target of acacetin in skin cancer

Carcinogenesis. 2014 Jan;35(1):123-30. doi: 10.1093/carcin/bgt266. Epub 2013 Aug 2.

Abstract

The identification of primary molecular targets of cancer-preventive phytochemicals is essential for a comprehensive understanding of their mechanism of action. In the present study, we investigated the chemopreventive effects and molecular targets of acacetin, a flavonoid found in Robinia p seudoacacia, also known as black locust. Acacetin treatment significantly suppressed epidermal growth factor (EGF)-induced cell transformation. Immunoblot analysis revealed that acacetin attenuated EGF-induced phosphorylation of Akt and p70(S6K), which are downstream effectors of phosphatidylinositol 3-kinase (PI3-K). An immunoprecipitation kinase assay of PI3-K and pull-down assay results demonstrated that acacetin substantially inhibits PI3-K activity by direct physical binding. Acacetin exhibited stronger inhibitory effects against anchorage-dependent and -independent cell growth in cells expressing higher PI3-K activity compared with those exhibiting relatively low PI3-K activity. Binding assay data combined with computational modeling suggest that acacetin binds in an adenosine triphosphate (ATP)-competitive manner with the p110α subunit of PI3-K and interacts with Val828, Glu826, Asp911, Trp760, Ile777, Ile825, Tyr813, Ile910 and Met900 residues. Acacetin was also found to significantly reduce SK-MEL-28 tumor growth and Akt phosphorylation in vivo. Taken together, these results indicate that acacetin is an ATP-competitive PI3-K inhibitor and a promising agent for melanoma chemoprevention.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Animals
  • Antineoplastic Agents, Phytogenic / pharmacology
  • Cell Proliferation / drug effects
  • Cell Transformation, Neoplastic / drug effects
  • Class Ia Phosphatidylinositol 3-Kinase / metabolism
  • Enzyme Inhibitors / pharmacology*
  • Epidermal Growth Factor / pharmacology
  • Flavones / metabolism
  • Flavones / pharmacology*
  • Mice
  • Mice, Nude
  • Molecular Docking Simulation
  • Phosphatidylinositol 3-Kinases / metabolism
  • Phosphoinositide-3 Kinase Inhibitors*
  • Phosphorylation / drug effects
  • Proto-Oncogene Proteins c-akt / metabolism
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / metabolism*
  • Tumor Cells, Cultured
  • Xenograft Model Antitumor Assays

Substances

  • Antineoplastic Agents, Phytogenic
  • Enzyme Inhibitors
  • Flavones
  • Phosphoinositide-3 Kinase Inhibitors
  • Epidermal Growth Factor
  • Adenosine Triphosphate
  • Class Ia Phosphatidylinositol 3-Kinase
  • Proto-Oncogene Proteins c-akt
  • acacetin